Friday, July 10, 2026

pharma · Dermatitis atopic · Cancer

Sanofi-Aventis U.S

Sanofi-aventis Healthcare Pty is a pharma organization headquartered in Sydney, AU. Primary therapeutic focus areas include Dermatitis atopic, Cancer, Immune system diseases, Asthma, Chronic Obstructive Pulmonary Disease

Bridgewater, USA HQ
177 Employees
TGA registrant Type
Company details
Status
Public
HQ
Bridgewater, USA
Employees
177
Programs
117
Drugs
148
Patents
0
Clinical program

BDR17530

Phase 1 · other · Healthy Volunteer

BDR17530 for Healthy Volunteer is a Phase 1 program (other) at Sanofi-aventis Healthcare Pty Ltd with 1 ClinicalTrials.gov record(s).

Internal code BDR17530

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Sanofi-aventis Healthcare Pty Ltd
Phase
Phase 1
Modality
other
Indication
Healthy Volunteer
Status
active
Trials
1